BDNF and melanoma: Importantly, we have noted upregulation of several pathways critical for melanoma biology and MAPK inhibitor resistance in areas of tumor-stroma interface, including ECM receptor interaction, insulin signaling, MAPK signaling, phosphatidylinositol signaling, and neurotrophin signaling (Figure 2B).5